TipRanks
Volatility is back on the menu. Last week brought Januarys trading to a close in what amounted to the stock markets worst month since October. The GameStop saga hogged the headlines as the retail buying frenzy for names with high short interest raised the possibility the market might be exhibiting bubble behavior. Add into the mix the slow rollout of Covid-19 vaccines and the fear of a delayed return to normalcy, and once again, uncertainty is engulfing Wall Street. The key to success in this environment is really the same as in normal times. Look for stocks with sound fundamentals and a history of success. Yes, past performance is no guarantee of future returns, but a history of share price growth is a good indicator. After all, growth stocks are growing for a reason. Weve used the TipRanks database to pull up the details on three such growth stocks that have shown sustained gains over the past year gains of 120% or more. And even better, for investors seeing a growth profile, Wall Streets analysts see continued growth ahead. Hyrecar, Inc. (HYRE) The gig economy has exploded in recent years, connecting people with skills to people with needs. Hyrecar fills a gap for car-less drivers, connecting car owners with idle vehicles to gig drivers (think Uber and Lyft) who need a vehicle. The Hyrecar service allows drivers to rent time in these vehicles, earning money from their transport or delivery routes while the cars owner earns a passive income from the rental fee. Hyrecar operates on the peer-to-peer model, and is available to subscribers as an online platform or a mobile app. In the past year 12 months, the companys shares have boomed. HYRE is up 228% in that time, riding especially high as economies opened up in 2H20. To put some numbers on the companys gains, revenue increased from $3.7 million in 3Q19 to $6.8 million in 3Q20 (the last reported quarter), a year-over-year gain of 83%. While Hyrecar currently runs a net loss like many tech-oriented startups that loss has moderated over the course of 2020. In 3Q19, EPS was negative 24 cents; in 3Q20, that had improved to negative 10 cents. In January 2021, the company announced partnerships with AmeriDrive Holdings, an automotive fleet manager, and Cogent Banks Specialty Lending Unit to increase the pool of available vehicles. The expected surge in vehicle availability has analysts bullish on Hyrecar. New strategic partnerships involving HYRE and four key players, including AmeriDrive Holdings (private) and Cogent Bank (private), aims to more than double the vehicle supply on HYREs platform in the next 12-18 months We view the announcement as a significant win for HYRE, which we believe creates a massive opportunity for HYRE to increase average active rentals to ~9,000 per day vs. ~2,800 in 2021, Maxim analyst Jack Vander Aarde noted. In line with this upbeat outlook, the 5-star analyst puts a Buy rating on HYRE along with an $18 price target. At that level, his target predicts an 82% upside in the coming year. (To watch Vander Aardes track record, click here) Over the past 3 months, only two other analysts have thrown the hat in with a view on the carsharing services player. The two additional Buy ratings provide HYRE with a Strong Buy consensus rating. With an average price target of $15.67, investors stand to take home a 59% gain, should the target be met over the next 12 months. (See HYRE stock analysis on TipRanks) Alpha and Omega Semiconductor (AOSL) Next up, Alpha and Omega, is a semiconductor maker with a wide portfolio of chipsets specifically designed for the power control requirements of advanced electronic devices. AOSLs chips are found in a range of common devices, including flat-screen TVs, LED lighting, portable PCs, smart phones and the power supply units for these products. In the fiscal 1Q21, the company reported $151.6 million in revenue, for a 28% year-over-year increase. Earnings, which had been negative prior to the fiscal Q1 report, turned positive with an EPS of 36 cents. The gain bodes well for the companys performance, now that the pandemic crisis is starting to recede. The second fiscal quarter results will be published on Thursday, February 4. Alpha and Omegas stock performance is also picking up, with shares rising 123% over the past 12 months. Growth like this is sure to attract attention, and it has. 5-star analyst Craig Ellis of B. Riley Securities, noted, Comms YE 5G smartphone unit strength lends an upside bias, and we like CY21s 2x YY growth potential... In Consumer, healthy next-gen gaming console uptake has follow-on product and design-in opportunities. So, we believe Comms, Compute, and Consumer end markets are performing quite well We expect above-industry AOSL growth" To this end, Ellis rates AOSL a Buy along with a $40 price target. This figure implies ~40% upside from current levels. (To watch Ellis track record, click here) Though not many have weighed in with an opinion on AOSL in the last 3 months, those who have are singing its praises. Overall, two analysts rate the semiconductor maker a Buy and the average price target of $37.50 implies ~30% upside for the upcoming year. (See AOSL stock analysis on TipRanks) Lands End (LE) The retail landscape has been shifting dramatically in recent years, and many venerable names have fallen by the wayside. Some, however, have survived. Lands End, founded almost 60 years ago, has built a reputation for quality in the clothing, footwear, and home dcor niche. The company brought in $1.45 billion for its fiscal year 2019, the last with full numbers available. From the 2020 numbers that have been published, it looks like Lands End is on track for steady growth. It posted year-over-year revenue gains in both Q2 and Q3 of 2020, indicating a quick recovery from the COVID crisis. The Q3 revenue was $360 million, up 5.8% from 3Q19 and up an even more impressive 15% from 2Q20. Meanwhile, the company has revised its Q4 guidance upward. Revenue is expected between $528 million and $533 million, up 4% at the midpoint. EPS is expected between 54 cents and 58 cents, for a 19% midpoint increase. Solid revenues through a difficult year have powered strong share appreciation. LE stock has gained a robust 126% over the past 52 weeks. Covering this stock for Craig-Hallum, analyst Alex Fuhrman writes, Lands End defied expectations in 2020 and is well positioned to grow in 2021 and beyond. The company proved its ability to execute in all environments as well as the strength of its branded e-commerce channel, which has grown more than 20% y/y over the past two reported quarters we envision continued e-commerce growth, as 2020s growth was likely the result of market share gains from brick-and-mortar foes rather than 'pantry loading,' while the retail and uniforms channels have potential for substantial growth ahead. Unsurprisingly, Fuhrman rates the stock a Buy, and his price target, at $35, implies ~27% growth potential in the next 12 months. (To watch Fuhrmans track record, click here) Some stocks fly under the radar, and LE is one of those. Fuhrman's is the only recent analyst review of this company, and it is decidedly positive. (See LE stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Read the original post:
Animal Genetics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product, Genetic Material, and Services and Geography. - Yahoo...
- Genetics, brain development, and mental health shape teen eating - News-Medical.Net - January 15th, 2025 [January 15th, 2025]
- Building Better Flu Shots Based on Antibody Responses and Genetics - Vax-Before-Travel - January 15th, 2025 [January 15th, 2025]
- Its in the Genes: Weight and Metabolism Determined by Genetics More Than Diet - Cville Right Now - January 15th, 2025 [January 15th, 2025]
- It's in the genes: Weight and metabolism determined by genetics more than diet - Medical Xpress - January 15th, 2025 [January 15th, 2025]
- Trump and Musk are obsessed with genetics but theres no science behind their simplistic views - The Guardian - January 1st, 2025 [January 1st, 2025]
- From Stonehenge's origins to ice age baby genetics how well did you follow this year's top archaeology stories? - Livescience.com - January 1st, 2025 [January 1st, 2025]
- William Thilly, MIT genetics professor who invented Apple Jacks cereal, dies at 79 - The Boston Globe - January 1st, 2025 [January 1st, 2025]
- Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- Using the PERC Database to Gather Insights on Epilepsy Genetics: Julie Ziobro, MD, PhD; John Schreiber, MD - Neurology Live - December 23rd, 2024 [December 23rd, 2024]
- Myriad Genetics' Breakthrough Cancer Test Named Top 10 Genomic Advance by Leading Journal - StockTitan - December 23rd, 2024 [December 23rd, 2024]
- Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- Surprising yields, impressive genetics and an early harvest in 2024 Ohio Ag Net - Ohio's Country Journal and Ohio Ag Net - December 9th, 2024 [December 9th, 2024]
- Using music to help people with dementia; supporting breastfeeding radiologists; genetics and Type 2 diabetes; plus other news stories with VUMC... - December 9th, 2024 [December 9th, 2024]
- Genetics and suicideWhats the link? - Genetic Literacy Project - December 9th, 2024 [December 9th, 2024]
- Genetics is all fun and games for a Rochester card game creator - Rochester Post Bulletin - November 28th, 2024 [November 28th, 2024]
- Community engagement conduct for genetics and genomics research: a qualitative study of the experiences and perspectives of key stakeholders in Uganda... - November 28th, 2024 [November 28th, 2024]
- Dietary restriction interventions: lifespan benefits need resilience and are limited by immune compromise and genetics - Nature.com - November 28th, 2024 [November 28th, 2024]
- Texas A&M Researchers Uncover Secrets Of Horse Genetics For Conservation, Breeding - Texas A&M University Today - November 20th, 2024 [November 20th, 2024]
- Myriad Genetics Announces Prequel Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy - GlobeNewswire - November 20th, 2024 [November 20th, 2024]
- Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance - November 20th, 2024 [November 20th, 2024]
- Precision mutational scanning: your multipass to the future of genetics - Nature.com - November 20th, 2024 [November 20th, 2024]
- Advancements of Haploid Technology in Crops: New Horizons in Breeding and Genetics - Frontiers - November 20th, 2024 [November 20th, 2024]
- Toward advances in retinoblastoma genetics in Kenya - Nature.com - November 12th, 2024 [November 12th, 2024]
- CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production - Nature.com - November 12th, 2024 [November 12th, 2024]
- Genetics Play Key Role in Animal Health and Welfare, Aggression and Handling - Farms.com - November 12th, 2024 [November 12th, 2024]
- Episode 174: Rudy Tanzi talks about genetics, aging and the hallmarks of Alzheimers - IHMC - October 26th, 2024 [October 26th, 2024]
- Ocuphire and Opus Genetics merge to develop IRD gene therapy - Pharmaceutical Technology - October 26th, 2024 [October 26th, 2024]
- The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - PR Newswire - October 26th, 2024 [October 26th, 2024]
- The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - WV News - October 26th, 2024 [October 26th, 2024]
- Faculty of Science | Protecting Canadas number one crop through genetics - UM Today - October 26th, 2024 [October 26th, 2024]
- Ocuphire and Opus Genetics merge to develop IRD gene therapy - Yahoo Finance - October 26th, 2024 [October 26th, 2024]
- Opinion | Fascinated by genetics? Where are the peas Trump made to fornicate? - The Washington Post - October 13th, 2024 [October 13th, 2024]
- Dietary restriction can extend lifespan but genetics matters more - Nature.com - October 13th, 2024 [October 13th, 2024]
- 'They have much stronger players' - Bangladesh assistant coach bizarrely blames 'genetics' for lack of six hitters in the team - Sporting News - October 13th, 2024 [October 13th, 2024]
- Medical Moment: Genetics and breast cancer with USA Health Genetic Counselor Cassie Gurganus - AOL - October 13th, 2024 [October 13th, 2024]
- Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer - Yahoo Finance - October 13th, 2024 [October 13th, 2024]
- An ideologically-based and misleading critique of how modern genetics is taught - Why Evolution Is True - October 13th, 2024 [October 13th, 2024]
- 2024 Mercedes-AMG C63 Review: Bold But Beholden to Its Genetics - Newsweek - October 2nd, 2024 [October 2nd, 2024]
- Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date - GlobeNewswire - October 2nd, 2024 [October 2nd, 2024]
- Digbi Health Launches an SEC-regulated Offering, Giving Millions the Opportunity to Invest in Groundbreaking Genetics and Gut Microbiome-based Care... - October 2nd, 2024 [October 2nd, 2024]
- The role of genetics in depression | Second Opinion - KCRW - September 23rd, 2024 [September 23rd, 2024]
- Tilapia genetics company Spring Genetics teams up with UK data firm to improve fish welfare - SeafoodSource - September 23rd, 2024 [September 23rd, 2024]
- Picky eating in kids is mostly due to genetics, study says - Motherly Inc. - September 23rd, 2024 [September 23rd, 2024]
- Research Shows That Fussy Eating In Children Is Mainly Influenced By Genetics - RTTNews - September 23rd, 2024 [September 23rd, 2024]
- Genetics colloquium: Chris Hittinger on the genomic making of metabolic niche breadth Sep. 11 - University of WisconsinMadison - September 15th, 2024 [September 15th, 2024]
- NIH Recognizes Yales Expertise in the Genetics of Rare Diseases - Yale School of Medicine - September 15th, 2024 [September 15th, 2024]
- SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing - PR Newswire - September 15th, 2024 [September 15th, 2024]
- Medicines race dilemma: What science says about genetics and health [PODCAST] - Kevin MD - September 15th, 2024 [September 15th, 2024]
- Researchers want to unlock genetics of the worlds tiniest animals - Popular Science - September 15th, 2024 [September 15th, 2024]
- Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout - Medical Device Network - September 15th, 2024 [September 15th, 2024]
- From farm to future: Technology in genetics - National Hog Farmer - September 2nd, 2024 [September 2nd, 2024]
- Editorial: Plant biotechnology and genetics for sustainable agriculture and global food security - Frontiers - September 2nd, 2024 [September 2nd, 2024]
- NSF Grant Brings Genetics Opportunities to Students in Alabama - Government Technology - September 2nd, 2024 [September 2nd, 2024]
- SBUs Ben Luft brings Lyme expertise to seminal paper on bacterial genetics and evolution - TBR News Media - September 2nd, 2024 [September 2nd, 2024]
- SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference - PR Newswire - September 2nd, 2024 [September 2nd, 2024]
- Singapores National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapores Multi-Ethnic... - August 5th, 2024 [August 5th, 2024]
- Fulgent Genetics Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - August 5th, 2024 [August 5th, 2024]
- Stopped clinical trials give evidence for the value of genetics - Nature.com - August 5th, 2024 [August 5th, 2024]
- What is DSD? Sex genetics and Olympic boxing controversy - Washington Examiner - August 5th, 2024 [August 5th, 2024]
- Fulgent Genetics Q2: Core Revenue Grows, but Profitability Is Still an Issue - The Motley Fool - August 5th, 2024 [August 5th, 2024]
- Viewpoint: Challenging yet another scientifically silly article claiming Black domination of sprinting and long distance running has nothing to do... - August 5th, 2024 [August 5th, 2024]
- Texas Company Trying To Resurrect Woolly Mammoths To Improve Genetics Of Bison - Cowboy State Daily - August 5th, 2024 [August 5th, 2024]
- Genetics confirms Berbers reached North Africa over 20,000 years ago; Arabs came in 7th Century CE - Down To Earth Magazine - August 5th, 2024 [August 5th, 2024]
- Unlocking plant genetics with telomere-to-telomere genome assemblies - Nature.com - July 26th, 2024 [July 26th, 2024]
- Carlo Ancelotti claims Jude Bellingham's 'genetics' are main reason behind Real Madrid & England superstar's meteoric rise to the top - Goal.com - July 26th, 2024 [July 26th, 2024]
- Genetics-based modeling estimates Idaho's wolf population was 1,150 in summer 2023 - Idaho Fish and Game - July 26th, 2024 [July 26th, 2024]
- Lung Cancer Research Foundation Joins Lung Cancer Advocacy Organizations and 23andMe to Launch Lung Cancer Genetics Study to Advance Research - PR... - July 26th, 2024 [July 26th, 2024]
- Fulgent Genetics (FLGT) Scheduled to Post Earnings on Friday - Defense World - July 26th, 2024 [July 26th, 2024]
- SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix - Financial Times - July 26th, 2024 [July 26th, 2024]
- LG Household & Health Care publishes research into the genetics of skin tone - GlobalCosmeticsNews - July 26th, 2024 [July 26th, 2024]
- Estonians gave their DNA to science now they're learning their genetic secrets - Nature.com - June 27th, 2024 [June 27th, 2024]
- Genetic clues to depression revealed in large study - PsyPost - June 27th, 2024 [June 27th, 2024]
- Move Over, Genghis Khan. Many Other Men Left Huge Genetic Legacies - Smithsonian Magazine - June 27th, 2024 [June 27th, 2024]
- 3X4 Genetics Selected as Partner for Preeminent Cancer Research and Treatment Nonprofit, The Metabolic Terrain ... - BioSpace - June 27th, 2024 [June 27th, 2024]
- NIFA Invests $6M in Animal Breeding, Genetics and Genomics | NIFA - National Institute of Food and Agriculture - June 27th, 2024 [June 27th, 2024]
- Arbel Harpak: Pursuing the Next Frontier in Genetics | Dell Medical School - Dell Medical School - June 27th, 2024 [June 27th, 2024]
- Coffee habits are partly linked to genetics, UC San Diego researchers say - NBC San Diego - June 27th, 2024 [June 27th, 2024]
- Advanced genetic tools help researchers ID new neurodevelopmental syndrome - Yale News - June 27th, 2024 [June 27th, 2024]
- Nutritious diet may protect against type 2 diabetes, regardless of genetics - News-Medical.Net - June 27th, 2024 [June 27th, 2024]